Neuro42 Company

Neuro42 is developing and commercializing advanced MRI technology for diagnosis and image-guided interventions.
Industry: Early Drug Development
Headquarters: Oakland, California, United States
Founded Date: 2020-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: 7800000
Last Funding Date: 2021-07-27
Last Funding Type: Series A

Visit Website
hello@neuro42.com
Register and Claim Ownership